Trial Profile
Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Metreleptin (Primary)
- Indications Lipodystrophy
- Focus Therapeutic Use
- 05 Jul 2021 Results published in the Journal of Clinical Endocrinology and Metabolism
- 20 May 2021 Results estimating the treatment effect of metreleptin compared to BSC on the metabolic complications of lipodystrophy in generalised lipodystrophy or partial lipodystrophy patients presented at the 26th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 02 Apr 2021 Results of a matched cohort analysis (of data from 3 studies NCT00025883, NCT01778556 and NCT00005905) assessing the effect of Leptin therapy on survival in generalized and partial Lipodystroph published in the Journal of Clinical Endocrinology and Metabolism